Wöllner, A.; Paul, A.; Arquilla, M.; Cao, J.; Lotsch, C.; Jungwirth, G.; Jassowicz, L.; von Deimling, A.; Unterberg, A.W.; Krieg, S.M.;
et al. Use of Tissue Specimens from Stereotactic Biopsies for Patient-Derived GBM Organoid-Based Drug Testing. Cells 2025, 14, 701.
https://doi.org/10.3390/cells14100701
AMA Style
Wöllner A, Paul A, Arquilla M, Cao J, Lotsch C, Jungwirth G, Jassowicz L, von Deimling A, Unterberg AW, Krieg SM,
et al. Use of Tissue Specimens from Stereotactic Biopsies for Patient-Derived GBM Organoid-Based Drug Testing. Cells. 2025; 14(10):701.
https://doi.org/10.3390/cells14100701
Chicago/Turabian Style
Wöllner, Amélie, Adrian Paul, Maddalena Arquilla, Junguo Cao, Catharina Lotsch, Gerhard Jungwirth, Lena Jassowicz, Andreas von Deimling, Andreas W. Unterberg, Sandro M. Krieg,
and et al. 2025. "Use of Tissue Specimens from Stereotactic Biopsies for Patient-Derived GBM Organoid-Based Drug Testing" Cells 14, no. 10: 701.
https://doi.org/10.3390/cells14100701
APA Style
Wöllner, A., Paul, A., Arquilla, M., Cao, J., Lotsch, C., Jungwirth, G., Jassowicz, L., von Deimling, A., Unterberg, A. W., Krieg, S. M., Jakobs, M., Warta, R., & Herold-Mende, C.
(2025). Use of Tissue Specimens from Stereotactic Biopsies for Patient-Derived GBM Organoid-Based Drug Testing. Cells, 14(10), 701.
https://doi.org/10.3390/cells14100701